Security key
45257U108
Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM)
CUSIP: 45257U108
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 113,446,633
- Total 13F shares
- 2,313,613
- Share change
- -291,835
- Total reported value
- $7,426,000
- Put/Call ratio
- 0%
- Price per share
- $3.21
- Number of holders
- 24
- Value change
- -$1,197,731
- Number of buys
- 4
- Number of sells
- 13
Report period
Q2 2022
Institutions
24
Top holders
10
IMNM full security history
Newer quarter: Q3 2022
Previous quarter: Q1 2022
Immunome Inc. SEC filings
Immunome Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45257U108
Recent filing periods:
Top shareholders of IMNM - Immunome Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Alpine Global Management, LLC |
13F
|
Company |
0.77%
|
877,235
|
$5,085,000 | — | 31 Mar 2022 | |
| Prentice Capital Management, LP |
13F
|
Company |
0.7%
|
792,321
|
$4,500,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.33%
|
370,536
|
$2,105,000 | — | 31 Mar 2022 | |
| Cerity Partners LLC |
13F
|
Company |
0.08%
|
93,546
|
$531,000 | — | 31 Mar 2022 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.08%
|
92,593
|
$556,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
81,406
|
$462,000 | — | 31 Mar 2022 | |
| Atom Investors LP |
13F
|
Company |
0.04%
|
39,770
|
$226,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.03%
|
39,568
|
$224,000 | — | 31 Mar 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
33,767
|
$192,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.03%
|
29,591
|
$168,000 | — | 31 Mar 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.03%
|
28,533
|
$162,000 | — | 31 Mar 2022 | |
| Ridgewood Investments LLC |
13F
|
Company |
0.02%
|
28,013
|
$159,000 | — | 31 Mar 2022 | |
| Magnus Financial Group LLC |
13F
|
Company |
0.02%
|
25,759
|
$146,000 | — | 31 Mar 2022 | |
| Baldwin Investment Management, LLC |
13F
|
Company |
0.02%
|
25,394
|
$144,000 | — | 31 Mar 2022 | |
| Sterling Investment Advisors, Ltd. |
13F
|
Company |
0.02%
|
21,627
|
$123,000 | — | 31 Mar 2022 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.02%
|
19,444
|
$110,000 | — | 31 Mar 2022 | |
| Laird Norton Wetherby Wealth Management, LLC |
13F
|
Company |
0.02%
|
17,881
|
$102,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.01%
|
16,798
|
$95,000 | — | 31 Mar 2022 | |
| J.P. Morgan Private Wealth Advisors LLC |
13F
|
Company |
0.01%
|
15,270
|
$87,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.01%
|
14,000
|
$80,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
13,732
|
$78,000 | — | 31 Mar 2022 | |
| Wealth Architects, LLC |
13F
|
Company |
0.01%
|
11,110
|
$63,000 | — | 31 Mar 2022 | |
| ETF MANAGERS GROUP, LLC |
13F
|
Company |
0%
|
3,670
|
$20,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,785
|
$10,000 | — | 31 Mar 2022 | |
| MassMutual Private Wealth & Trust, FSB |
13F
|
Company |
0%
|
514
|
$3,000 | — | 31 Mar 2022 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0%
|
375
|
$2,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
106
|
$1,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
96
|
$1,000 | — | 31 Mar 2022 | |
| Michael Widlitz |
3/4/5
|
Director |
—
class O/S missing
|
3,750
|
— | — | 28 May 2021 |
Institutional Holders of Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) as of Q2 2022
As of 30 Jun 2022,
Immunome Inc. - Common Stock, par value $0.0001 per share (IMNM) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,313,613 shares.
The largest 10 holders included
Prentice Capital Management, LP, Alpine Global Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, CERITY PARTNERS LLC, BlackRock Inc., STATE STREET CORP, ROYAL BANK OF CANADA, Magnus Financial Group LLC, and Baldwin Investment Management, LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
26
Q2 2022 holders
24
Holder diff
-2
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.